BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Binicier OB, Pakoz ZB. CA 19-9 levels in patients with acute pancreatitis due to gallstone and metabolic/toxic reasons. Rev Assoc Med Bras (1992). 2019;65:965-970. [PMID: 31389506 DOI: 10.1590/1806-9282.65.7.965] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Lahoud RM, O'Shea A, El-Mouhayyar C, Atre ID, Eurboonyanun K, Harisinghani M. Tumour markers and their utility in imaging of abdominal and pelvic malignancies. Clin Radiol 2021;76:99-107. [PMID: 32861463 DOI: 10.1016/j.crad.2020.07.033] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
2 Weng Y, Jin J, Huo Z, Shi Y, Jiang Y, Deng X, Peng C, Shen B. Robotic-assisted versus open distal pancreatectomy for benign and low-grade malignant pancreatic tumors: a propensity score-matched study. Surg Endosc 2021;35:2255-64. [PMID: 32458287 DOI: 10.1007/s00464-020-07639-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
3 Giannis D, Moris D, Barbas AS. Diagnostic, Predictive and Prognostic Molecular Biomarkers in Pancreatic Cancer: An Overview for Clinicians. Cancers (Basel) 2021;13:1071. [PMID: 33802340 DOI: 10.3390/cancers13051071] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 O'Neill RS, Stoita A. Biomarkers in the diagnosis of pancreatic cancer: Are we closer to finding the golden ticket? World J Gastroenterol 2021; 27(26): 4045-4087 [PMID: 34326612 DOI: 10.3748/wjg.v27.i26.4045] [Cited by in F6Publishing: 1] [Reference Citation Analysis]